Prognostic Significance of Interim 11 C-Methionine PET for the Treatment of Primary Central Nervous System Lymphoma (PCNSL)

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_35
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Primary Central Nervous System Lymphoma

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2018English

Primary Central Nervous System Lymphoma

Contemporary Neurosurgery
2010English

Primary Central Nervous System Lymphoma

Journal of Neurosurgery
SurgeryNeurology
1985English

The Role of Rituximab in Primary Central Nervous System Lymphoma (Pcnsl): A Systematic Review and Meta-Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

The Methionine Synthase Polymorphism D919G Alters Susceptibility to Primary Central Nervous System Lymphoma

British Journal of Cancer
Cancer ResearchOncology
2004English

The Process of Somatic Hypermutation Increases Polyreactivity for Central Nervous System Antigens in Primary Central Nervous System Lymphoma.

Haematologica
Hematology
2020English

Primary Central Nervous System T-Cell Lymphoma of the Brain

The Open Neurosurgery Journal
2011English

Neurolymphomatosis Appeared Following Primary Central Nervous System Lymphoma

Internal Medicine
Internal MedicineMedicine
2017English

Primary Central Nervous System Lymphoma: A Curable Disease

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy